Paratek Pharmaceuticals

Paratek

This company develops and supplies antibiotics and specialty medicines for healthcare providers treating serious infectious diseases and osteoporosis.

Nabriva

This biopharmaceutical company develops and commercialises novel antibiotics for patients with serious infections caused by drug-resistant bacteria.

Iterum Therapeutics

This pharmaceutical company develops and commercialises oral and intravenous antibiotics for patients with multi-drug resistant infections, including urinary tract infections.

Melinta Therapeutics

This biopharmaceutical company develops and commercialises antibiotics and antifungals to treat drug-resistant infections in hospital and clinic settings.

Peninsula Pharmaceuticals

The company develops and commercialises broad-spectrum antibiotics to treat patients with life-threatening infections, including hospital-acquired pneumonia and urinary tract infections.

Phaxiam

The company develops bacteriophage-based treatments to combat antibiotic-resistant bacterial infections for patients with severe hospital-acquired or chronic respiratory conditions.

Acurx Pharmaceuticals

This biopharmaceutical company develops small molecule antibiotics to treat patients with bacterial infections caused by priority pathogens.

Durata Therapeutics

The company develops and commercialises intravenous antibiotics to treat patients with acute bacterial skin and skin structure infections.